Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00289419 |
Recruitment Status :
Completed
First Posted : February 9, 2006
Last Update Posted : May 7, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Arthroplasty, Replacement, Hip | Drug: Epidural Ropivacaine, morphine Drug: Ropivacaine, Ketorolac and Adrenaline | Phase 4 |
Sufficient postoperative pain relief after total hip replacement is necessary to achieve normal mobilisation and a reduction of the surgical stress response. After total hip replacement epidural treatment has proven superior, with regards to pain relief, than treatment with parenteral infusions and periphery nerve blocks. Even though epidural treatment gives excellent pain relief adverse effect as motor block, urine retention, hypotension and itching occurs regularly which delays rehabilitation.
Treatment with the administration of local anesthetic in the operating field has shown its efficiency in reducing postoperative pain with a low incidence of adverse effects after various surgical procedures.
This study compares continuous epidural infusion of ropivacaine added morphine to a new technique, where ropivacaine, ketorolac and adrenaline is used to infiltrate the tissue around the hip joint during surgery, and is injected by an intraarticular catheter 8 hours postoperative.
Data of pain scores, analgesia consumption, adverse effects and mobilisation is collected for the first 4 postoperative days.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Postoperative Analgesia After Total Hip Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Intraarticular Bolus Injection. |
Study Start Date : | February 2005 |
Actual Primary Completion Date : | February 2006 |
Actual Study Completion Date : | March 2006 |

Arm | Intervention/treatment |
---|---|
Active Comparator: A |
Drug: Epidural Ropivacaine, morphine
Infusion rate 4 ml/h in 48 h Solution 200 ml Ropivacaine 2mg/ml added 1 ml morphine 10 mg/ml |
Experimental: B |
Drug: Ropivacaine, Ketorolac and Adrenaline
Wound infiltration: 100 ml Ropivacaine 2 mg/ml added 1 ml Ketorolac 30 mg/ml and 0,5 ml adrenaline 1 mg/ml Bolus injection: 20 ml Ropivacaine 7,5mg/ml added 1 ml Ketorolac 30 mg/ml and 0,5 ml adrenaline 1 mg/ml |
- Consumption af analgesics [ Time Frame: 96 h ]
- Side effects [ Time Frame: 96 h ]
- Mobilization level [ Time Frame: 8 h ]
- Pain scores VAS [ Time Frame: 96 h ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients admitted consecutively to primary total hip arthroplasty due to arthrosis
Exclusion Criteria:
- Patients unable to provide informed consent
- Patients with contraindications for spinal anesthesia
- Patients with known hypersensitivity towards the used drugs
- Patients with severe chronic neurogenic pain
- Patients with Rheumatoid arthritis
- Patients with a daily opioid consumption

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00289419
Denmark | |
Orthopedic Center, Aarhus University Hospital | |
Aarhus, Denmark, 8000 |
Principal Investigator: | Kjeld Søballe, Professor | Orthopedic Center, Aarhus University Hospital, Aarhus, Denmark |
Responsible Party: | Professor Kjeld Soballe, University of Aarhus |
ClinicalTrials.gov Identifier: | NCT00289419 |
Other Study ID Numbers: |
20040199 |
First Posted: | February 9, 2006 Key Record Dates |
Last Update Posted: | May 7, 2008 |
Last Verified: | May 2008 |
Arthroplasty, Replacement, Hip Anesthetics, Local Pain, Postoperative |
Ketorolac Epinephrine Racepinephrine Morphine Ropivacaine Epinephryl borate Analgesics, Opioid Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Anesthetics, Local Anesthetics |
Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Adrenergic beta-Agonists Bronchodilator Agents Autonomic Agents Anti-Asthmatic Agents |